Marseille-Kliniken AG : 27.01.2012 Annual General Meeting of Marseille-Kliniken AG supports positive development of the company more

Here you will find news of topical events in the Group. 27.01.2012 Annual General Meeting of Marseille-Kliniken AG supports positive development of the company New supervisory board member Prof. Dr. Enderlein elected Expansion of the authorized capital to € 18.7 million At the request of the administration former board members were not relieved Hamburg, 27 January 2012 - Today's Annual General Meeting, located at the company's headquarter in Hamburg, approved all significant applications of the administration with a majority of over 90 percent. This represented approximately 65 percent of the share capital. On administration's recommendation, both former directors, Stefan Herzberg and Dr. Thomas Klaue, were not relieved. Prof. Dr. Dietmar Enderlein was elected to the Supervisory Board. The long-time expert in the health care industry is following Mathias Kampmann, who retired on 17 January 2012. The decision on the creation of new authorized capital was supported by the major shareholder and the representatives of shareholder protection communities. Overall, the meeting took place under the close observation of journalists and numerous experts in health care. "The decisions of our shareholders will create a reliable basis for our operational success.", said Michael Thanheiser, chairman of the company. Contact: Investor Relations Christian Hillermann Hillermann Consulting Investor Relations for Marseille-Kliniken AG Poststraße 14-16 20354 Hamburg Germany Tel.: +49 (0) 40 / 3202791-0